Clinical Trial: Frontal Gamma Coherence Neurofeedback for Patients With Schizophrenia

U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07659938) titled 'Frontal Gamma Coherence Neurofeedback for Patients With Schizophrenia' on June 15.

Brief Summary: This preliminary, randomized, double-blind, placebo-controlled clinical trial will evaluate frontal gamma coherence neurofeedback in adults with schizophrenia. Thirty participants will be randomly assigned to receive either active neurofeedback or placebo neurofeedback using a study-provided mobile platform. Participants will complete baseline assessments in person at the University of California San Diego, receive training on home use of the neurofeedback platform, and complete twice-weekly 30-minute sessions at home for 12 weeks. Part...